Annual Retained Earnings
-$13.53 B
-$559.00 M-4.31%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual retained earnings is currently -$13.53 billion, with the most recent change of -$559.00 million (-4.31%) on 31 December 2023. During the last 3 years, it has fallen by -$2.59 billion (-23.64%). TEVA annual retained earnings is now -191.13% below its all-time high of $14.85 billion, reached on 31 December 2015.TEVA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$14.96 B
-$437.00 M-3.01%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly retained earnings is currently -$14.96 billion, with the most recent change of -$437.00 million (-3.01%) on 30 September 2024. Over the past year, it has dropped by -$1.09 billion (-7.83%). TEVA quarterly retained earnings is now -198.98% below its all-time high of $15.11 billion, reached on 31 March 2016.TEVA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.3% | -7.8% |
| 3 y3 years | -23.6% | -44.2% |
| 5 y5 years | -127.2% | -111.7% |
TEVA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -28.5% | at low | -44.2% | at low |
| 5 y | 5 years | -127.2% | at low | -121.7% | at low |
| alltime | all time | -191.1% | at low | -199.0% | at low |
Teva Pharmaceutical Industries Limited Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$14.96 B(+3.0%) |
| June 2024 | - | -$14.52 B(+6.2%) |
| Mar 2024 | - | -$13.67 B(+1.0%) |
| Dec 2023 | -$13.53 B(+4.3%) | -$13.53 B(-2.4%) |
| Sept 2023 | - | -$13.87 B(-0.6%) |
| June 2023 | - | -$13.95 B(+6.6%) |
| Mar 2023 | - | -$13.09 B(+0.9%) |
| Dec 2022 | -$12.97 B(+23.2%) | -$12.97 B(+11.3%) |
| Sept 2022 | - | -$11.66 B(-0.5%) |
| June 2022 | - | -$11.72 B(+2.0%) |
| Mar 2022 | - | -$11.48 B(+9.1%) |
| Dec 2021 | -$10.53 B(-3.8%) | -$10.53 B(+1.5%) |
| Sept 2021 | - | -$10.37 B(-2.7%) |
| June 2021 | - | -$10.66 B(-1.9%) |
| Mar 2021 | - | -$10.87 B(-0.7%) |
| Dec 2020 | -$10.95 B(+57.4%) | -$10.95 B(-1.4%) |
| Sept 2020 | - | -$11.10 B(+64.5%) |
| June 2020 | - | -$6.75 B(-2.0%) |
| Mar 2020 | - | -$6.89 B(-1.0%) |
| Dec 2019 | -$6.96 B(+16.8%) | -$6.96 B(-1.6%) |
| Sept 2019 | - | -$7.07 B(+4.7%) |
| June 2019 | - | -$6.75 B(+11.4%) |
| Mar 2019 | - | -$6.06 B(+1.8%) |
| Dec 2018 | -$5.96 B(+56.7%) | -$5.96 B(+93.9%) |
| Sept 2018 | - | -$3.07 B(+7.3%) |
| June 2018 | - | -$2.86 B(+6.5%) |
| Mar 2018 | - | -$2.69 B(-29.3%) |
| Dec 2017 | -$3.80 B(-127.9%) | -$3.80 B(-151.2%) |
| June 2017 | - | $7.43 B(-46.2%) |
| Mar 2017 | - | $13.81 B(+1.5%) |
| Dec 2016 | $13.61 B(-8.4%) | $13.61 B(-9.2%) |
| Sept 2016 | - | $14.99 B(+0.0%) |
| June 2016 | - | $14.99 B(-0.8%) |
| Mar 2016 | - | $15.11 B(+1.7%) |
| Dec 2015 | $14.85 B(+2.9%) | $14.85 B(+1.3%) |
| Sept 2015 | - | $14.66 B(-1.2%) |
| June 2015 | - | $14.84 B(+1.7%) |
| Mar 2015 | - | $14.59 B(+1.1%) |
| Dec 2014 | $14.44 B(+15.2%) | $14.44 B(+3.0%) |
| Sept 2014 | - | $14.02 B(+4.3%) |
| June 2014 | - | $13.44 B(+3.5%) |
| Mar 2014 | - | $12.99 B(+3.6%) |
| Dec 2013 | $12.54 B(+1.5%) | $12.54 B(+0.8%) |
| Sept 2013 | - | $12.43 B(+3.7%) |
| June 2013 | - | $11.99 B(-5.7%) |
| Mar 2013 | - | $12.71 B(+2.9%) |
| Dec 2012 | $12.35 B(+9.4%) | $12.35 B(+0.8%) |
| Sept 2012 | - | $12.25 B(-2.3%) |
| June 2012 | - | $12.54 B(+5.3%) |
| Mar 2012 | - | $11.91 B(+5.5%) |
| Dec 2011 | $11.28 B(+21.0%) | $11.28 B(+2.9%) |
| Sept 2011 | - | $10.97 B(+6.9%) |
| June 2011 | - | $10.26 B(+3.8%) |
| Mar 2011 | - | $9.88 B(+6.0%) |
| Dec 2010 | $9.32 B(+40.0%) | $9.32 B(+6.9%) |
| Sept 2010 | - | $8.73 B(+11.3%) |
| June 2010 | - | $7.84 B(+17.7%) |
| Dec 2009 | $6.66 B | $6.66 B(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $5.90 B(+7.0%) |
| Mar 2009 | - | $5.51 B(+4.3%) |
| Dec 2008 | $5.29 B(+4.9%) | $5.29 B(-12.8%) |
| Sept 2008 | - | $6.07 B(+9.8%) |
| June 2008 | - | $5.53 B(+8.5%) |
| Mar 2008 | - | $5.09 B(+1.0%) |
| Dec 2007 | $5.04 B(+48.4%) | $5.04 B(+10.8%) |
| Sept 2007 | - | $4.55 B(+11.0%) |
| June 2007 | - | $4.10 B(+11.8%) |
| Mar 2007 | - | $3.67 B(+7.9%) |
| Dec 2006 | $3.40 B(+10.3%) | $3.40 B(+13.3%) |
| Sept 2006 | - | $3.00 B(+22.4%) |
| June 2006 | - | $2.45 B(+21.4%) |
| Mar 2006 | - | $2.02 B(-34.5%) |
| Dec 2005 | $3.08 B(+42.0%) | $3.08 B(+9.5%) |
| Sept 2005 | - | $2.82 B(+8.8%) |
| June 2005 | - | $2.59 B(+8.4%) |
| Mar 2005 | - | $2.39 B(+10.0%) |
| Dec 2004 | $2.17 B(+10.7%) | $2.17 B(+13.2%) |
| Sept 2004 | - | $1.92 B(+13.0%) |
| June 2004 | - | $1.70 B(+12.9%) |
| Mar 2004 | - | $1.50 B(-23.4%) |
| Dec 2003 | $1.96 B(+45.7%) | $1.96 B(+9.3%) |
| Sept 2003 | - | $1.79 B(+8.3%) |
| June 2003 | - | $1.66 B(+13.1%) |
| Mar 2003 | - | $1.47 B(+8.9%) |
| Dec 2002 | $1.35 B(+38.7%) | $1.35 B(+11.2%) |
| Sept 2002 | - | $1.21 B(+7.5%) |
| June 2002 | - | $1.13 B(+7.8%) |
| Mar 2002 | - | $1.04 B(+7.6%) |
| Dec 2001 | $970.42 M(+33.2%) | $970.42 M(+7.5%) |
| Sept 2001 | - | $902.80 M(+8.6%) |
| June 2001 | - | $831.31 M(+7.3%) |
| Mar 2001 | - | $774.96 M(+6.4%) |
| Dec 2000 | $728.34 M(+19.6%) | $728.34 M(+4.4%) |
| Sept 2000 | - | $697.43 M(+9.5%) |
| June 2000 | - | $637.05 M(-0.7%) |
| Mar 2000 | - | $641.83 M(+5.4%) |
| Dec 1999 | $608.91 M(+20.3%) | $608.91 M(-0.6%) |
| Sept 1999 | - | $612.30 M(+3.1%) |
| June 1999 | - | $593.90 M(+5.5%) |
| Mar 1999 | - | $562.80 M(+11.2%) |
| Dec 1998 | $506.10 M(+10.8%) | $506.10 M(-3.4%) |
| Sept 1998 | - | $524.10 M(+5.1%) |
| June 1998 | - | $498.90 M(+3.5%) |
| Mar 1998 | - | $481.80 M(+5.5%) |
| Dec 1997 | $456.70 M(+21.3%) | $456.70 M(+21.3%) |
| Dec 1996 | $376.40 M(+17.7%) | $376.40 M(+17.7%) |
| Dec 1995 | $319.80 M(+47.2%) | $319.80 M(+47.2%) |
| Dec 1994 | $217.30 M(+35.9%) | $217.30 M(+35.9%) |
| Dec 1993 | $159.90 M(+37.1%) | $159.90 M(+37.1%) |
| Dec 1992 | $116.60 M(+30.6%) | $116.60 M(+30.6%) |
| Dec 1991 | $89.30 M(+16.4%) | $89.30 M(+16.4%) |
| Dec 1990 | $76.70 M(+35.3%) | $76.70 M(+35.3%) |
| Dec 1989 | $56.70 M(+36.3%) | $56.70 M(+36.3%) |
| Dec 1988 | $41.60 M(+74.1%) | $41.60 M(+74.1%) |
| Mar 1987 | $23.90 M(+1.3%) | $23.90 M(+1.3%) |
| Mar 1986 | $23.60 M | $23.60 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual retained earnings?
- What is the all time high annual retained earnings for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual retained earnings year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly retained earnings?
- What is the all time high quarterly retained earnings for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly retained earnings year-on-year change?
What is Teva Pharmaceutical Industries Limited annual retained earnings?
The current annual retained earnings of TEVA is -$13.53 B
What is the all time high annual retained earnings for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual retained earnings is $14.85 B
What is Teva Pharmaceutical Industries Limited annual retained earnings year-on-year change?
Over the past year, TEVA annual retained earnings has changed by -$559.00 M (-4.31%)
What is Teva Pharmaceutical Industries Limited quarterly retained earnings?
The current quarterly retained earnings of TEVA is -$14.96 B
What is the all time high quarterly retained earnings for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly retained earnings is $15.11 B
What is Teva Pharmaceutical Industries Limited quarterly retained earnings year-on-year change?
Over the past year, TEVA quarterly retained earnings has changed by -$1.09 B (-7.83%)